Benard Clarisse, Chauzeix Jasmine, Blancher Antoine, Puissant-Lubrano Bénédicte
Laboratoire d'Immunologie, CHU de Toulouse, France.
Laboratoire d'Immunologie, CHU de Toulouse, France.
Clin Biochem. 2016 Jul;49(10-11):828-31. doi: 10.1016/j.clinbiochem.2016.03.008. Epub 2016 Apr 9.
The intrathecal production of IgG is part of the diagnosis criteria for Multiple Sclerosis. Its assessment requires both quantitative (quantification of IgG and albumin in serum and cerebrospinal fluid (CSF)) and qualitative assays (isoelectric focusing). We have evaluated the analytical performances of the SPAPLUS® immunoturbidimeter (The Binding Site®) for the quantification of IgG and albumin in serum and CSF.
Within-day and between-day precision, linearity and carry-over were assessed. Results obtained with SPAPLUS® were compared to those obtained with the nephelometer IMMAGE® 800, including albumin quotient and CSF IgG index. Isoelectric focusing was performed and considered as the gold standard for assessment of intrathecal production of IgG.
The within-day and the between-day precisions were obtained at two concentration levels and were below the recommendations of the manufacturer and of the French Society of Clinical Biology. Our evaluation confirmed the linearity of the assays and the absence of contamination. An agreement above 94% was observed between the results obtained with SPAPLUS® and those obtained with IMMAGE® 800. The use of the new reference material DA470k did not significantly modify IgG and albumin values. The confrontation of CSF IgG index and isoelectric focusing results led to a sensitivity of 79% and a specificity of 97% of CSF IgG index quantified on SPAPLUS® for the presence of oligoclonal bands at IEF. The sensitivity of intrathecal IgG calculated with the Reiber's hyperbolic formula was 47.4% and specificity was 97% for the presence of oligoclonal bands at IEF. Automatic rerun managed by the device for concentrations outside the measuring range was satisfactory.
The SPAPLUS® immunoturbidimeter displays good analytical performances for the parameters evaluated in this work.
鞘内IgG生成是多发性硬化诊断标准的一部分。其评估需要定量分析(测定血清和脑脊液(CSF)中的IgG和白蛋白)和定性分析(等电聚焦)。我们评估了SPAPLUS®免疫比浊仪(The Binding Site®)对血清和脑脊液中IgG和白蛋白定量分析的性能。
评估日内和日间精密度、线性和携带污染。将SPAPLUS®获得的结果与IMMAGE® 800比浊仪获得的结果进行比较,包括白蛋白商和脑脊液IgG指数。进行等电聚焦,并将其视为评估鞘内IgG生成的金标准。
在两个浓度水平获得了日内和日间精密度,均低于制造商和法国临床生物学协会的建议值。我们的评估证实了分析方法的线性和无污染。SPAPLUS®与IMMAGE® 800获得的结果之间的一致性超过94%。使用新的参考物质DA470k并未显著改变IgG和白蛋白值。脑脊液IgG指数与等电聚焦结果的对比显示,对于等电聚焦时寡克隆带的存在,SPAPLUS®定量的脑脊液IgG指数的敏感性为79%,特异性为97%。用赖伯双曲线公式计算的鞘内IgG对于等电聚焦时寡克隆带存在的敏感性为47.4%,特异性为97%。该设备对超出测量范围的浓度进行自动重新运行的效果令人满意。
SPAPLUS®免疫比浊仪在本研究评估的参数方面表现出良好的分析性能。